Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02291055
Title Phase 1-2 Study of ADXS11-001 or MEDI4736 Alone or Combo In Cervical or HPV+ Head & Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors NCT02291055
Indications

cervix carcinoma

head and neck squamous cell carcinoma

Therapies

Durvalumab

ADXS11-001

Age Groups: adult
Covered Countries USA


No variant requirements are available.